U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07052942) titled 'Individualizing Treatment for Asthma in Primary Care (Full Study)' on June 30.
Brief Summary: While asthma therapy is becoming more individualized based on asthma phenotypes, other than eosinophil counts for biologics, we know little about how to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foundation of care for all individuals with persistent asthma. But ICS use is not without possible long term side effects.
We will compare two currently available approaches to reduce AEX in primary care patients: (1) use of inhaled corticosteroids (ICS) as part of rescue therapy, also known as MART (Mai...